Diagnostic accuracy of serum asialo-α1-acid glycoprotein concentration for the differential diagnosis of liver cirrhosis and hepatocellular carcinoma

Clinica Chimica Acta

Volumn 369, Issue 1, 2006, Pages 46-51

  Kim, Kyoung A ^a   Lee, Eun Young ^b   Kang, Ji Hyun ^a   Lee, Hee Gu ^a   Kim, Jae Wha ^a   Kwon, Dur Han ^a   Jang, Ye Jin ^a   Yeom, Young Il ^a   Chung, Tai Wha ^c   Kim, Yung Dai ^c   Yoon, Do Young ^d   Song, Eun Young ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Ulsan Institute of Health and Environment   (South Korea)

^c Bio21 Foundation Center   (South Korea)

^d Konkuk University   (South Korea)

Author keywords

Antibody lectin sandwich assay; Asialo 1 acid glycoprotein; Asialoglycoproteins; Hepatic disease serum marker; Hepatocellular carcinoma; Liver cirrhosis

Indexed keywords

ASIALO ALPHA ACID GLYCOPROTEIN; BIOCHEMICAL MARKER; GLYCOPROTEIN; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; ADOLESCENT; ADULT; AGED; ANTIBODY LECTIN SANDWICH ASSAY; AREA UNDER THE CURVE; ARTICLE; BIOACCUMULATION; CANCER DIAGNOSIS; CHILD; CHRONIC HEPATITIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INFANT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NEWBORN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC;

ADOLESCENT; ADULT; ASIALOGLYCOPROTEINS; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFANT; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ROC CURVE;

EID: 33744485866     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.01.002     Document Type: Article

References (24)

1. Turner G.A. N-Glycosylation of serum proteins in disease and its investigation using lectins. Clin Chim Acta 208 (1992) 149-171
2. Baenziger J.U. The oligosaccharides of plasma glycoproteins. In: Putnam F.W. (Ed). The plasma proteins (1984), Academic Press, New York 272-316
3. Ashwell G., and Morell A.G. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol 41 (1974) 99-128
4. Neufeld E.F., and Ashwell G. Carbohydrate recognition systems for receptor-mediated pinocytosis. In: Lennartz W.J. (Ed). The biochemistry of glycoproteins and proteoglycans (1979), Plenum Press, New York 241-266
5. Well D.A., Wilson G., and Hubbard A.I. The galactose specific recognition system of mammalian liver: the route of ligand internalization in rat hepatocytes. Cell 21 (1980) 79-83
6. Bridges K., Harford J., Ashwell G., and Klausner R.D. Fate of receptor and ligand during endocytosis of ASGPs by isolated hepatocytes. Proc Natl Acad Sci USA 79 (1982) 350-354
7. Weigel P.H., and Oka J.A. Endocytosis and degradation mediated by the asialoglycoprotein receptor in isolated rat hepatocytes. J Biol Chem 257 (1982) 1201-1207
8. Sawamura T., and Shiozaki Y. Mechanism and clinical relevance of increased concentrations of circulating asialoglycoproteins. In: Wu G.Y., and Wu C.H. (Eds). Liver diseases (1991), M Dekker Inc, New York 215-234
9. Marshall J.S., Green A.M., Pensky J., Williams S., Zinn A., and Carlson D.M. Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage. J Clin Invest 54 (1974) 555-562
10. Reffetoff S., Fang V.S., and Marshall J.S. Studies on human thyroxine-binding globulin (TBG): IX. Some physical, chemical, and biological properties of radioiodinated TBG and partially desialylated TBG. J Clin Invest 56 (1975) 177-187
11. Arima T., and Sci D. Serum glycoprotein in liver disease: VIII. Desialoglycoproteins in the liver cirrhosis. Gastroentrol Jpn 14 (1979) 349-352
12. 1 antitrypsin desialylation in liver disease. Hepatology 3 (1983) 356-359
13. Sawamura T., Kawasato S., Tsuda M., Naitoh Y., Shiozaki Y., and Sameshima Y. Clinical application of the measurement of serum asialoglycoproteins to estimate residual liver function in patients with chronic liver diseases with or without hepatocellular carcinoma. Gastroenterol 20 (1985) 201-208
14. Van L., and Ashwell G. The binding of desialated glycoproteins by plasma membranes of rat liver. Development of a quantitative inhibition assay. J Biol Chem 247 (1972) 4633-4640
15. 1-acid glycoprotein fucosylation for liver cirrhosis in patients undergoing hepatic biopsy. Clin Chem 48 (2002) 2195-2201
16. Song E.Y., Kim K.A., Kim Y.D., Lee E.Y., Lee H.S., Kim H.J., Ahn B.M., and Chung T.W. Increase of serum asialo-a1 acid glycoprotein concentration in patients with hepatic cirrhosis and hepatocellular carcinoma as measured by antibody-lectin sandwich assay. Hepatol Res 26 (2003) 311-317
17. Zweig M.H., and Campell G. Receiver-operating characteristics (ROC) plots: a functional evaluation tool in clinical medicine. Clin Chem 39 (1993) 929-935
18. 1-acid glycoprotein during cirrhosis. Prog Clin Biol Res 300 (1989) 215-218
19. Thompson S., Matta K.L., and Turner G.A. Changes in fucose metabolism associated with heavy drinking and smoking: a preliminary report. Clin Chim Acta 201 (1991) 59-64
20. Mann A.C., Record C.O., Self C.H., and Turner G.A. Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: large changes in glycosylation associated with alcoholic liver disease. Clin Chim Acta 227 (1994) 69-78
21. Kondo M., Hada T., Fukui K., Iwasaki A., Higashino K., and Yasukawa K. Enzyme-linked immunosorbent assay (ELISA) for Aleuria aurantia lectin-reactive serum cholinesterase to differentiate liver cirrhosis and chronic hepatitis. Clin Chim Acta 243 (1995) 1-9
22. Hada T., Kondo M., Yasukawa K., Amuro Y., and Higashino K. Discrimination of liver cirrhosis from chronic hepatitis by measuring the ratio of Aleuria aurantia lectin-reactive serum cholinesterase to immunoreactive protein. Clin Chim Acta 281 (1999) 37-46
23. Naitoh A., Aoyagi Y., and Asakura H. Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 14 (1999) 436-445
24. Aoyagi Y., Saitoh A., Suzuki Y., Igarashi K., Oguro M., and Yokota T. Fucosylation index of α-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis. Hepatology 17 (1993) 50-52